Skip to main content

Table 5 Baseline characteristics of follow-up data stratified by the tertile of VFA

From: Association between visceral fat area and metabolic syndrome in individuals with normal body weight: insights from a Chinese health screening dataset

Variables

T1

(23.80–100.00)

T2

(100.10-153.50)

T3

(153.60-317.80)

P-value

N

133

132

133

 

Sex, n (%)

   

< 0.001

Female

96 (72.18)

68 (51.52)

29 (21.80)

 

Male

37 (27.82)

64 (48.48)

104 (78.20)

 

Ethnic group, n (%)

   

0.604

Non-han

5 (3.76)

2 (1.52)

0 (0.00)

 

Han

128 (96.24)

130 (98.48)

133 (100.00)

 

Marital status, n (%)

   

0.054

Unmarried

3 (2.26)

3 (2.27)

5 (4.51)

 

Married

130 (97.74)

129 (97.73)

127 (95.49)

 

Age, years, n (%)

   

< 0.001

< 40

23 (17.29)

10 (7.58)

1 (0.75)

 

>=40, < 60

89 (66.92)

89 (67.42)

71 (53.38)

 

>=60

21 (15.79)

33 (25.00)

61 (45.86)

 

Current smoking, n (%)

   

< 0.001

No

132 (99.25)

124 (93.94)

118 (88.72)

 

Yes

1 (0.75)

8 (6.06)

15 (11.28)

 

Current drinking, n (%)

   

0.018

No

133 (100.00)

132 (100.00)

129 (96.99)

 

Yes

0 (0.00)

0 (0.00)

4 (3.01)

 

BMI, kg/m2

20.64 ± 1.37

21.97 ± 1.44

22.62 ± 1.09

< 0.001

WC, cm

73.83 ± 6.55

78.25 ± 4.73

84.31 ± 5.23

< 0.001

SBP, mmHg

116.75 ± 16.66

129.13 ± 19.83

134.65 ± 17.69

< 0.001

DBP, mmHg

68.92 ± 10.14

73.53 ± 11.40

79.11 ± 10.67

< 0.001

TP, g/L

71.12 ± 4.13

72.01 ± 3.80

72.19 ± 4.16

0.073

ALT, U/L

15.10 (11.80,19.90)

18.10 (13.25, 23.65)

19.35 (15.07, 24.20)

0.003

AST, U/L

20.05 ± 6.93

21.97 ± 7.01

21.81 ± 6.54

0.041

Cre, µmol/L

63.25 ± 10.17

64.67 ± 10.85

77.75 ± 31.60

< 0.001

BUN, mmol/L

4.68 ± 1.08

5.13 ± 1.42

5.48 ± 1.97

< 0.001

eGFR, mL/min/1.73m2

96.90 ± 16.77

98.72 ± 17.68

91.73 ± 19.93

0.006

TC, mmol/L

4.79 ± 0.82

5.01 ± 1.09

4.76 ± 1.13

0.109

LDL-C, mmol/L

2.67 ± 0.68

2.78 ± 0.92

2.74 ± 0.90

0.561

TG, mmol/L

1.14 ± 0.44

1.41 ± 0.80

1.43 ± 0.67

< 0.001

HDL-C, mmol/L

1.49 ± 0.28

1.51 ± 0.35

1.35 ± 0.28

< 0.001

FBG, mmol/L

4.86 ± 0.45

5.12 ± 0.73

5.47 ± 1.02

< 0.001

VFA, cm2

69.18 ± 20.03

126.54 ± 15.01

199.01 ± 35.36

< 0.001

SFA, cm2

73.56 ± 31.92

97.25 ± 39.20

87.51 ± 25.77

< 0.001

TFA, cm2

142.74 ± 43.59

223.78 ± 44.64

286.52 ± 46.82

< 0.001

VFA/SFA

1.22 ± 0.92

1.55 ± 0.74

2.46 ± 0.82

< 0.001

MetS, n (%)

   

< 0.001

No

124 (93.23)

103 (78.03)

65 (48.87)

 

Yes

9 (6.77)

29 (21.97)

68 (51.13)

 
  1. BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TP, total protein; ALT, alanine aminotransferase; AST, aspartate transaminase; Cre, Creatinine; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; VFA, visceral fat area; SFA, subcutaneous fat area; TFA, total fat area; MetS, metabolic syndrome. OR, odds ratio; CI, confidence interval. Except for ALT, which are expressed as medians (upper and lower quartiles), all other continuous variables are expressed as mean ± standard deviation, and categorical variables are expressed as counts (%). For categorical variables, reference groups are as indicated. For continuous variables, OR represent the risk per unit increase
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X